Borr Drilling Limited – Dividend declaration and key information relating to the cash distribution for the third quarter 2024 November 7, 2024
First patient treated in new phase II clinical trial at Radiumhospitalet in Oslo – promising use of Lytix cancer treatment in patients with early-stage melanoma November 6, 2024